AUSTIN, Texas, Oct. 7 /PRNewswire/ -- SpineSmith Partners, a Texas-based medical device company, today announced the company has received FDA clearance for commercial sale in the United States of its VisuALIF Interbody Fusion Implant System. The VisuALIF System is being launched this week and is currently on display at the North American Spine Society's annual meeting in Orlando, Florida.
The VisuALIF is a two-piece, stand alone device indicated for intervertebral body fusion of the lumbar spine. VisuALIF is the first modular lumbar interbody device with an open-face allowing in situ graft placement, tactile feedback with face plate attachment and device placement flush with the anterior aspect of the vertebrae. The device is available in a range of product sizes and configurations designed to meet surgeon requirements across a wide spectrum of patient anatomy.
SpineSmith's General Partner, Kevin Dunworth, believes the VisuALIF will offer a unique solution for surgeons.
"The VisuALIF incorporates an anterior open-face allowing surgeons to visualize disc and end plate preparation leading to optimum graft placement with respect to available volume. With our launch at NASS, the VisuALIF is 'Now Open for Fusion,'" said Dunworth.
About SpineSmith Partners LP
SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. SpineSmith takes a different approach from other companies, utilizing a collaborative approach between scientists, engineers and spine surgeons. It's this unique approach that gives spine surgeons the ability to directly impact the direction of their product portfolio, ensuring applicability and achieving the highest standards of patient care.
Founded in Austin, Texas, in 2006, SpineSmith has developed a range of devices with direct surgeon input into the design of spine technology. www.spinesmithusa.com
SOURCE SpineSmith Partners, LP